| Receptor for advanced glycation end products (RAGE) and mechanisms and therapeutic opportunities in diabetes and cardiovascular disease: insights from human subjects and animal … L Egaña-Gorroño, R López-Díez, G Yepuri, LS Ramirez, S Reverdatto, ... Frontiers in cardiovascular medicine 7, 37, 2020 | 168 | 2020 |
| Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons M Rotger, TR Glass, T Junier, J Lundgren, JD Neaton, ES Poloni, ... Clinical infectious diseases 57 (1), 112-121, 2013 | 83 | 2013 |
| Differential microRNA expression profile between stimulated PBMCs from HIV-1 infected elite controllers and viremic progressors L Egaña-Gorroño, T Escribà, N Boulanger, AC Guardo, A León, ... PLoS One 9 (9), e106360, 2014 | 56 | 2014 |
| Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy L Egana-Gorrono, E Martínez, B Cormand, T Escriba, J Gatell, M Arnedo Aids 27 (4), 529-538, 2013 | 46 | 2013 |
| RAGE impairs murine diabetic atherosclerosis regression and implicates IRF7 in macrophage inflammation and cholesterol metabolism L Senatus, R López-Díez, L Egaña-Gorroño, J Liu, J Hu, G Daffu, Q Li, ... JCI insight 5 (13), 2020 | 42 | 2020 |
| Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice MB Manigrasso, P Rabbani, L Egaña-Gorroño, N Quadri, L Frye, B Zhou, ... Science translational medicine 13 (621), eabf7084, 2021 | 35 | 2021 |
| Allograft inflammatory factor-1 supports macrophage survival and efferocytosis and limits necrosis in atherosclerotic plaques L Egaña-Gorroño, P Chinnasamy, I Casimiro, VM Almonte, D Parikh, ... Atherosclerosis 289, 184-194, 2019 | 28 | 2019 |
| MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: relationship with antiviral immune response and disease progression L Egaña-Gorroño, AC Guardo, ME Bargallo, E Planet, E Vilaplana, ... PloS one 11 (5), e0155245, 2016 | 24 | 2016 |
| Inhibition of smooth muscle β-catenin hinders neointima formation after vascular injury DF Riascos-Bernal, P Chinnasamy, JN Gross, V Almonte, ... Arteriosclerosis, thrombosis, and vascular biology 37 (5), 879-888, 2017 | 22 | 2017 |
| Cholesterol efflux responds to viral load and CD4 counts in HIV+ patients and is dampened in HIV exposed O Tort, T Escribà, L Egaña-Gorroño, E de Lazzari, M Cofan, E Fernandez, ... Journal of Lipid Research 59 (11), 2108-2115, 2018 | 16 | 2018 |
| Inflammation Meets Metabolism Roles: for the Receptor for Advanced Glycation End Products Axis in Cardiovascular Disease L Senatus, M MacLean, L Arivazhagan, L Egaña-Gorroño, R López-Díez, ... Immunometabolism 3 (3), e210024, 2021 | 13 | 2021 |
| Contribution of genetic background and antiretroviral therapy to body fat changes in antiretroviral-naive HIV-infected adults L Egaña-Gorroño, E Martínez, I Pérez, T Escribà, P Domingo, JM Gatell, ... Journal of Antimicrobial Chemotherapy 69 (11), 3076-3084, 2014 | 12 | 2014 |
| Diabetes and cardiovascular complications: the epidemics continue R Lopez-Diez, L Egana-Gorrono, L Senatus, A Shekhtman, R Ramasamy, ... Current Cardiology Reports 23 (7), 74, 2021 | 10 | 2021 |
| Allograft inflammatory factor-1-like is not essential for age dependent weight gain or HFD-induced obesity and glucose insensitivity D Parikh, DF Riascos-Bernal, L Egaña-Gorroño, S Jayakumar, V Almonte, ... Scientific reports 10 (1), 3594, 2020 | 9 | 2020 |
| PLX3397, a CSF1 receptor inhibitor, limits allotransplantation-induced vascular remodelling VM Almonte, U Uriyanghai, L Egaña-Gorroño, D Parikh, ... Cardiovascular research 118 (12), 2718-2731, 2022 | 7 | 2022 |
| Utility of systematic isolation of immune cell subsets from HIV-infected individuals for miRNA profiling ME Bargalló, AC Guardo, MJ Maleno, L Miralles, L Egaña-Gorroño, ... Journal of Immunological Methods 442, 12-19, 2017 | 7 | 2017 |
| RAGE impairs murine diabetic atherosclerosis regression and implicates IRF7 in macrophage inflammation and cholesterol metabolism. JCI Insight. 2020; 5 (13): e137289 L Senatus, R López-Díez, L Egaña-Gorroño, J Liu, J Hu, G Daffu, Q Li, ... | 6 | |
| DIAPH1 mediates progression of atherosclerosis and regulates hepatic lipid metabolism in mice L Senatus, L Egaña-Gorroño, R López-Díez, S Bergaya, JF Aranda, ... Communications biology 6 (1), 280, 2023 | 4 | 2023 |
| Differential subcutaneous adipose tissue gene expression patterns in a randomized clinical trial of efavirenz or lopinavir-ritonavir in antiretroviral-naive patients L Egana-Gorrono, E Martinez, P Domingo, M Lonca, T Escriba, ... Antimicrobial Agents and Chemotherapy 58 (11), 6717-6723, 2014 | 4 | 2014 |
| Association study of lipoprotein (a) genetic markers, traditional risk factors, and coronary heart disease in HIV-1-infected patients L Egaña-Gorroño, E Martínez, T Escribà, M Calvo, JM Gatell, M Arnedo Frontiers in Immunology 3, 367, 2012 | 3 | 2012 |
